BRADLEY STUART EDWARD has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are CTG PHARMA S R L, ILE BIOPROJET SOC CIV and SELVI & C SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Bradley Stuart Edward | 12 |
#2 | Procter Martin James | 9 |
#3 | Thomas Gerard Hugh | 9 |
#4 | Krulle Thomas Martin | 6 |
#5 | Rowley Robert John | 6 |
#6 | Fyfe Matthew Colin Thor | 6 |
#7 | Jeevaratnam Revathy Perpetua | 4 |
#8 | Sambrook Smith Colin Peter | 3 |
#9 | Murray Peter John | 3 |
#10 | Swain Simon Andrew | 2 |
Publication | Filing date | Title |
---|---|---|
US2009221644A1 | Gpcr Agonists | |
WO2005085245A1 | Pyrrolopyridine-2-carboxylic acid hydrazides | |
WO2004104001A2 | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |